Abstract
BackgroundAdjuvant therapy in early-stage endometrial cancer has not shown a clear overall survival benefit, and hence, patient selection remains crucial.ObjectiveTo determine whether women with high-intermediate risk, early-stage endometrial cancer with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have